Tammy Furlong - 15 May 2025 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Signature
/s/ Robert Yang, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
15 May 2025
Net transactions value
-$235
Form type
4
Filing time
19 May 2025, 16:15:05 UTC
Previous filing
19 Feb 2025
Next filing
24 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Furlong Tammy CHIEF FINANCIAL OFFICER C/O ELEVATION ONCOLOGY, INC., 101 FEDERAL STREET, SUITE 1900, BOSTON /s/ Robert Yang, Attorney-in-Fact 19 May 2025 0001984204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELEV Common Stock Options Exercise +2,643 +32% 10,859 15 May 2025 Direct F1
transaction ELEV Common Stock Tax liability $235 -784 -7.2% $0.2998 10,075 15 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Restricted Stock Unit Options Exercise $0 -2,343 -8.3% $0.000000 25,782 15 May 2025 Common Stock 2,343 Direct F1, F2, F3
transaction ELEV Restricted Stock Unit Options Exercise $0 -300 -12% $0.000000 2,100 15 May 2025 Common Stock 300 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F3 The RSUs do not expire; they either vest or are canceled prior to the vesting date.
F4 25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.